Growth-Stage Raises: Healthcare AI and Biotech Lead
The largest single-company raise of the day came from the healthcare sector.
- XCures raised $46M in a Series B led by Innovius Capital to apply AI to messy, unstructured patient records, helping providers and researchers make sense of fragmented clinical data.
- Tissium, a French biotech using a novel polymer-based approach to reconstruct damaged tissue, closed a dual package of approximately 30M euros in equity and up to 30M euros in debt financing, giving it a substantial runway to advance its regenerative medicine platform toward commercialization.
Seed and Pre-Seed: European AI Infrastructure Dominates
A cluster of early-stage European rounds reflected continued investor appetite for AI tooling, efficiency software, and vertical SaaS.
- Ora Computing (Vienna) raised 3.5M euros in a seed round led by Constructor Capital and Greencode Ventures to compress and optimize large AI foundation models for faster, cheaper inference.
- Compri (Milan) secured 3.2M euros in a seed round led by Picus Capital to build AI-powered procurement software for industrial companies.
- Zelara (Berlin) closed 3M euros in pre-seed funding led by NAP to develop an AI-native lifecycle marketing and customer engagement platform.
- Wakeline (Dusseldorf) raised 2.1M euros in a pre-seed round led by TechVision Fonds to build continuously adaptive AI systems that update in production without full retraining.
- SuperPlane raised $2.6M in a pre-seed round led by Credo Ventures to layer AI-native workflow tooling on top of production infrastructure management for engineers.
Early-Stage: Fintech and Sustainability
- Daya raised $2.4M in pre-seed funding, backed by Alliance DAO, to build stablecoin payment rails for cross-border business transactions in Africa, joining a growing cohort of fintechs betting on stablecoins as a practical settlement layer for the continent.
- LabCycle (UK) secured approximately 430K pounds, including 180K pounds from the British Design Fund, to commercialize its AutoDecon system for safely recycling contaminated lab plastics that would otherwise be incinerated.
Fund Closes: Capital Consolidates at Scale
Two significant fund announcements underscore the sustained appetite for deploying capital into technology and enterprise software.
- Main Capital Partners closed its Main Capital IX and Main Foundation III vehicles at a combined 5.25B euros, reinforcing its position as one of Europe's largest dedicated enterprise software investors.
- Valor Equity Partners is targeting $2.5B for its Fund VII, according to Bloomberg, continuing the firm's long-running focus on operationally intensive growth companies.
- Nucleo Ventures (formerly Fortech Ventures) launched a 34M euro fund focused on startups and SMEs across Central and Eastern Europe, adding regional coverage to an area that remains undercapitalized relative to Western European markets.
Editorial Perspective
Today's activity points to a few durable themes. First, AI efficiency is becoming its own investable category: startups like Ora Computing and Wakeline are not building new models but making existing ones smaller, faster, and more adaptive, a wedge that resonates with enterprises facing steep inference costs. Second, the concentration of pre-seed and seed capital in European AI tooling suggests that founders and investors alike see this moment as an infrastructure build-out, not just a product cycle. Third, the dual Tissium raise combining equity and debt signals that biotech is borrowing a financing structure more common in growth software, using non-dilutive capital to extend runway without giving up additional equity. Taken together, the day's raises reflect a market that is maturing in its AI ambitions while still placing early bets on infrastructure that does not yet exist at scale.